Electroceutical Devices Market is forecasted to witness a thriving growth by 2026
Electroceuticals
is recently coined term for an old therapeutic modality,
which broadly encompass all the bioelectric medicine. It includes any
type of electrical stimulation, which affects and modify functions of
the body and neural implants such as cochlear implants, retinal
implants or spinal cord stimulators, cardiac pacemakers, and
implantable defibrillators. Over a period of time, electroceutical
expanded their applicability to include deep brain stimulation and
the electrical stimulation of the vagus nerve. Electroceuticals are
also called as bioelectronics, which encompass tiny electronic
implants, which are capable to treat wide range of chronic diseases
such as diabetes, asthma, arthritis, hypertension and other heart
ailments, and gastrointestinal diseases.
Increasing
Engagement of Key Players to Accelerate Drug Discovery and
Development Process is expected to Aid in the Market Growth
Collaborations, advancements in technology, innovations in the field
of bioelectric medicines such as non-invasive devices are the major
factors driving growth of the bioelectric medicine market. For
instance, in October 2016, the U.S. National Institutes of Health
(NIH) announced US$ 20 million funding for the treatment of disease
with electrical stimulation, which aims to improve maps of the
peripheral nervous system—the body’s electrical wiring—and
generate sophisticated systems that can hack into its codes.
Moreover, the funding is part of a US$ 248 million, seven-year
program, which the NIH Common Fund announced in 2014.
Furthermore, in 2016, GlaxoSmithKline Plc. (GSK) merged with Google’s
parent company Alphabet to set up a new bioelectric company called
Galvani Bioelectronics, which will benefit over 2 billion people
suffering from chronic diseases. GSK invested around US$ 615 million
for the development of Galvani Bioelectronics.
Global Key
Players:
Key players operating in electroceutical devices market include
Medtronic plc, Abbott Laboratories, Cochlear Ltd. Sonova Holding AG,
Advanced Bionics AG, Boston Scientific Corporation, electroCore,
Inc., Biotronik, ReShape Lifesciences, Inc., and LivaNova, PLC.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1958
Detailed
Segmentation:
• Global Electroceutical Devices Market, By Product:
◦ Cardiac Pacemakers
◦ Implantable Cardioverter Defibrillators
◦ Retinal Implants
◦ Cochlear Implants
◦ Spinal cord Stimulators
◦ Deep brain Stimulators
◦ Others
• Global Electroceutical Devices Market, By Modality:
◦ Implantable Electroceutical Devices
◦ Non-Invasive Electroceutical Devices
◦ Global Electroceutical Devices Market, By Application:
◦ Pain Management
◦ Wound Healing
◦ Atrial Fibrillation
◦ Coronary Artery Disease
◦ Diabetes
◦ Arthritis
◦ Hypertension
◦ Gastrointestinal Diseases
◦ Other Applications
• Global Electroceutical Devices Market, By End User:
◦ Hospitals
◦ Academic Research Institutions
◦ Ambulatory Surgical Centers
• Global Electroceutical Devices Market, By Geography:
◦ North America
◦ Europe
◦ Asia Pacific
◦ Latin America
◦ Middle East
◦ Africa
About Coherent
Market Insights
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Comments
Post a Comment